arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Healthcare Triangle, Inc.

HCTI

$3.59 ▼ -0.96 (-21.10%) at close

7 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Healthcare Triangle, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 18.8% ↗

Op. Margin -70.5% ↘

ROIC None

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$13.89M

↑ +18.8% —

Net Income Profit after all expenses

$-9.48M

↓ -58.8% —

Operating Margin Operating profit as % of sales

-70.5%

↓ -73.5% 4th

FCF / Share Free cash flow per share

$-0.38

↑ +46.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	18.8% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+56%)	-64.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-640%)	-27.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-330%)	30.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+151%)	12.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	—	—
EPS Growth YoY (%)	99.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-578985.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-11.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-1202.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—
Net Income Growth YoY (%)	-58.8% Weak ↓ Weak Declining Year-over-year change in net income	51.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-28.4% Weak Weak Year-over-year change in net income	-61.5% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	—	—	46.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-191.1% Weak Weak Year-over-year change in free cash flow	-841.2% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-32.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-30.8% Weak Weak Compound annual revenue growth over 3 years	1.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-15.0% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-70.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-452%)	-40.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-303%)	-34.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-271%)	-22.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-213%)	-15.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-176%)	3.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	—
Effective Tax Rate (%) (%)	—	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	9.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-68.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-555%)	-51.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-440%)	-37.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-348%)	-20.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-240%)	-16.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-212%)	7.5% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	—
FCF Margin (%) (%)	-119.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-9.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-20.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-2.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.74x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	-0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	—	—	-2115.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-84.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	24.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-43.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-242.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-112.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	10.6% Good Good Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	-77.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-519%)	-36.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	54.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+194%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	6.37x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1316%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-57%)	0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	—	—
Interest Coverage (x)	-17.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-49.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	14.96x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$3.11M	$2.63M	$2.19M	$1.07M	$439.29K	$-1.40M	$-974.83K
Debt / EBITDA (x)	-1.18x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.69x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.34x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	$7.85	$12.54	$1.20	$1.12	—
Basic EPS, GAAP (USD)	$-152.30	$-16.91K	$-2.92	$-2.63	$-0.20	$0.08	—
Free Cash Flow per Share (USD)	—	—	$-0.38	$-0.72	$-0.25	$-0.03	—
Book Value per Share (USD)	—	—	$0.12	$2.97	$0.46	$0.16	—
Tangible Book Value per Share (USD)	—	—	$-0.71	$2.66	$0.42	$0.16	—
Basic Weighted Avg Shares (shares)	61,873	353	4.23M	3.66M	29.43M	27.90M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$359.00K	$-5.62M	$-2.39M	$1.60M	$5.55M	$1.25M	—
Total Equity (USD)	—	—	$538.00K	$12.39M	$16.13M	$4.33M	$1.97M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Jun 16, 2025 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$13.89M	$11.70M	$33.20M	$45.89M	$35.27M	$31.34M	—
Depreciation Expense (USD)	$705.00K	$889.00K	$7.23M	$3.37M	$1.42M	$803.19K	—
Net Income, GAAP (USD)	$-9.48M	$-5.97M	$-12.34M	$-9.61M	$-5.95M	$2.35M	—
Operating Cash Flow (USD)	$-16.52M	$-1.08M	$-1.61M	$-2.60M	$-7.29M	$-734.67K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 25 quarters

Healthcare Triangle, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCTI with peers